Brief Resolved Unexplained Events 2.0 (BRUE 2.0) Criteria for Infants

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۳۶۵ • واحد: days

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
brue 2 0 assessment
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Not BRUE0–0
  • Very Low Risk1–5
  • Low Risk6–15
  • Moderate Risk16–30
Direct Clinical Answer

The Brief Resolved Unexplained Events 2.0 (BRUE 2.0) Criteria for Infants calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include age under 1 year. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Classifies unexplained events and improves on the original BRUE criteria by providing sophisticated risk prediction models for serious underlying conditions and event recurrence in infants <1 year old. Uses derived models to predict risk of serious diagnosis and recurrent events.

Clinical Indication

The Brief Resolved Unexplained Events 2.0 (BRUE 2.0) Criteria for Infants is indicated for bedside clinical practice to support Classifies unexplained events and improves on the original BRUE criteria by providing sophisticated risk prediction models for serious underlying conditions and event recurrence in infants <1 year old. Uses derived models to predict risk of serious diagnosis and recurrent events.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: Risk models are based on multi-center validation studies.

Formula & Variables:

Risk of Serious Condition = [e^x / (1 + e^x)] * 100, where x = -2.9 - 0.0046*(Age in days) + 1.22*(History of similar event) + 0.35*(Abnormal medical history). Risk of Recurrence calculated using additional factors including multiple event clusters, prematurity, and specific event characteristics.

Input Parameters

NameTypeRequiredDescription
age_under_1_yearstringYesIs the infant less than 1 year old?
asymptomatic_on_presentationstringYesIs the infant asymptomatic on presentation (no URI symptoms, no fever)?
no_explanation_after_examstringYesNo explanation for event after history and physical exam?
sudden_brief_resolved_episodestringYesHistory of sudden, brief, and now resolved episode?
cyanosis_or_pallorstringYesEpisode included cyanosis or pallor?
breathing_changesstringYesEpisode included absent, decreased, or irregular breathing?
tone_changesstringYesEpisode included marked change in tone (hyper or hypotonia)?
altered_responsivenessstringYesEpisode included altered level of responsiveness?
age_in_daysintegerYesAge of infant in days (for risk prediction models)(days)
history_similar_eventstringYesHistory of similar events in the past?
abnormal_medical_historystringYesAbnormal medical history or concerning findings?
multiple_event_clustersstringYesMultiple event clusters or episodes occurring together?
prematuritystringYesHistory of prematurity (born <37 weeks gestational age)?

Score Interpretation & Guidance

RangeStageDescription
0–0Not BRUEDoes not meet BRUE criteria
1–5Very Low RiskBRUE with very low risk for serious condition or recurrence
6–15Low RiskBRUE with low risk for serious condition or recurrence
16–30Moderate RiskBRUE with moderate risk for serious condition or recurrence
31–100High RiskBRUE with high risk for serious condition or recurrence

Evidence-Based References (EBM)

  • Tieder JS, Bonkowsky JL, Etzel RA, et al. Brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants. Pediatrics. 2016;137(5):e20160590. doi: 10.1542/peds.2016-0590.DOI: 10.1542/peds.2016-0590
  • Merritt JL, Quinonez RA, Bonkowsky JL, et al. A framework for evaluation of the higher-risk infant after a brief resolved unexplained event. Pediatrics. 2021;148(1):e2021050798. doi: 10.1542/peds.2021-050798.DOI: 10.1542/peds.2021-050798
  • Ramgopal S, Karim SA, Subramanian S, Kaderli AA, Fitzgerald M, Ramesh A. Epidemiology of brief resolved unexplained events: a systematic review. Arch Dis Child. 2019;104(11):1074-1081. doi: 10.1136/archdischild-2018-316866.DOI: 10.1136/archdischild-2018-316866

Related calculators